Cell modification method using essential genes as markers and optionally recycling these

US9951339B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9951339-B2
Application numberUS-201314427698-A
CountryUS
Kind codeB2
Filing dateSep 19, 2013
Priority dateSep 19, 2012
Publication dateApr 24, 2018
Grant dateApr 24, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention relates to a method for modification of a host cell at a target locus, which method comprises: providing a host cell comprising, at a first locus, at least two site-specific recombination sites and a nucleic acid having an essential function or encoding a product having an essential function; introducing into the host cell, at the target locus, a further nucleic acid having the essential function or encoding for a product having the essential function; and carrying out recombination at the first locus via the at least two site-specific recombination sites, so that the nucleic acid having an essential function or encoding a product having an essential function is rendered non-functional, thereby to modify the host cell at the target locus. The invention also relates to a cell obtainable by a method of the invention.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for producing a biological compound of interest, which method comprises transforming a host cell with a nucleic acid encoding the biological compound of interest or a compound involved in synthesis of the biological compound of interest and culturing the resulting host cell under conditions conducive to production of the biological compound of interest, wherein the host cell is obtained by a method comprising: providing a host cell comprising, at a first locus, at least two site-specific recombination sites and a nucleic acid having an essential function or encoding a product having an essential function; introducing into the host cell, at a second locus, by homologous recombination, a further nucleic acid having the essential function or encoding for a product having the essential function together with the nucleic acid encoding the biological compound of interest or a compound involved in synthesis of the biological compound of interest; and carrying out recombination at the first locus via the at least two site-specific recombination sites, so that the nucleic acid having an essential function or encoding a product having an essential function, positioned at the first locus, is rendered non-functional, thereby to modify the host cell at the second locus, wherein the nucleic acid encoding the biological compound of interest or a compound involved in synthesis of the biological compound of interest is introduced at the second locus, wherein the host cell, when deficient in the nucleic acid having an essential function or encoding a product having an essential function, is non-viable under all conditions and on any medium. 2. The method according to claim 1 , further comprising isolating the biological compound of interest from culture broth. 3. The method according to claim 1 , wherein introduction into the host cell of the further nucleic acid having the essential function or encoding for a product having the essential function at the second locus results in replacement of nucleic acid sequence at the second locus with the further nucleic acid having the essential function or encoding for a product having the essential function. 4. The method according to claim 1 , wherein at least two of the site-specific recombination sites flank the nucleic acid having an essential function or encoding a product having an essential function at the first locus. 5. The method according to claim 1 , wherein at least two of the site-specific recombination sites flank a sequence encoding a recombinase, said recombinase recognizes at least two of the site-specific recombination sites. 6. The method according to claim 5 , wherein the recombinase is tyrosine recombinase. 7. The method according to claim 5 , wherein expression of the recombinase is under control of an inducible promoter. 8. The method according to claim 1 , wherein the essential function is an essential function in fungi. 9. The method according to claim 1 , wherein introducing into the host cell, at a second locus, a further nucleic acid having the essential function or encoding for a product having the essential function; and carrying out recombination at the first locus via the at least two site-specific recombination sites, so that the nucleic acid having an essential function or encoding a product having an essential function is rendered non-functional are carried out simultaneously, separately or sequentially. 10. The method according to claim 1 , wherein a further copy of the essential nucleic acid is introduced at the locus together with at least two site-specific recombination sites. 11. The method according to claim 10 , which further comprises: introducing into the host cell, at a further second locus, a further copy of the nucleic acid having the essential function or encoding for a product having the essential function; and carrying out recombination at the second locus via the at least two site-specific recombination sites, so that the nucleic acid having an essential function or encoding a product having an essential function is rendered non-functional. 12. The method according to claim 11 , which comprises one or more further cycles of: introducing into the host cell, at a further second locus, a further copy of the nucleic acid having the essential function or encoding for a product having the essential function; and rendering non-functional the nucleic acid having an essential function or encoding a product having an essential function introduced in the previous introduction cycle via recombination of the at least two site-specific recombination sites flanking that essential gene. 13. The method according to claim 1 , wherein the cell is a prokaryotic, archaeal or eukaryotic cell. 14. The method according to claim 1 , wherein the host cell is a fungal cell. 15. The method according to claim 14 , wherein the fungal cell is selected from the group consisting of an Aspergillus cell, a Chrysosporium cell, a Penicillium cell, a Saccharomyces cell, a Rasamsonia cell, a Talaromyces cell, and a Trichoderma cell. 16. The method according to claim 11 , wherein introducing into the host cell, at a further second locus, of a further copy of the nucleic acid having the essential function or encoding for a product having the essential function occurs by introducing said sequence together with at least two site-specific recombination sites. 17. The method according to claim 12 , wherein introducing into the host cell, at a further second locus, of a further copy of the nucleic acid having the essential function or encoding for a product having the essential function occurs by introducing said sequence together with at least two site-specific recombination sites. 18. A method for transformation of a host cell with a nucleic acid of interest, which method comprises: providing a host cell comprising, at a first locus, at least two site-specific recombination sites flanking a nucleic acid having an essential function or encoding a product having an essential function; introducing into the host cell, at a second locus, a nucleic acid of interest and a further nucleic acid having the essential function or encoding for a product having the essential function; and removing the nucleic acid having the essential function or encoding for a product having the essential function at the first locus via recombination of the at least two site-specific recombination sites, thereby to transform the host cell with a nucleic acid of interest, wherein the host cell, when deficient in the nucleic acid having an essential function or encoding a product having an essential function, is non-viable under all conditions and on any medium.

Assignees

Inventors

Classifications

  • for yeasts · CPC title

  • for fungi · CPC title

  • C12N15/65Primary

    using markers (enzymes used as markers C12N15/52) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9951339B2 cover?
The invention relates to a method for modification of a host cell at a target locus, which method comprises: providing a host cell comprising, at a first locus, at least two site-specific recombination sites and a nucleic acid having an essential function or encoding a product having an essential function; introducing into the host cell, at the target locus, a further nucleic acid having the es…
Who is the assignee on this patent?
Dsm Ip Assets Bv
What technology area does this patent fall under?
Primary CPC classification C12N15/65. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Apr 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).